Published in Women's Health Weekly, January 23rd, 2003
Independent studies, conducted by international clinical investigators, showed a direct correlation between the Ki-67 Antigen Expression Test, used to detect breast cancer proliferation through biopsy, and the BDS. Wolfgang Gatzemeier and Alberto Costa (The Maugeri Foundation, Pavia, Italy) presented a prospective study of 103 patients showing statistical significances between BDS and Ki-67 labeling in highly proliferating patient populations. Jack Cuzick (Imperial College Fund,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly